Approaching GOIS - Fifth Session

Approaching GOIS - Fifth Session

by Site Admin -
Number of replies: 0

 logo

 

 Global Oncology University ( GO-U)

 

Approaching “Global Oncology-Implementing Science” GOIS courses   

 

 5th  session Wednesday  Nov. , 2023 , at 4.00-5.15 pm GMT

 

 To join and login to GOIS Here

 

Direct zoom link to the session Here

 

Schedule:

 

 - Live introduction, then

 

1- Clinical Trials and Framework for Medical Research 

 

By: Prof David Kerr and Prof. Rachel Kerr, Oxford University, UK   

 

 2- Clinical trials among selected patients Versus real data among world populations

 

By Dr. Dr. Elizabeth Charlotte Moser MD PhD MBA, , Netherlands and USA                                                                                    

 

 

 

3-A Scientific brief on close the cancer divide. By: Prof. Ahmed Elzawawy                                                                             

 

  Q& A  & Comments & suggestions

 

Plus sending questions, comments and suggestions via e-mails & web  

 

Please visit www.gois.website

 

 

 

For any inquiry : feedback@icedoc.website

 

 

 

Faculty of the 5th  session:

david

Professor David Kerr CBE MD PhD DSc FRCP FRCGP FACP FESMO FMedSci , UK : David contributes to Oxford as Professor of Cancer Medicine, where he has worked with colleagues to build a new Institute for Cancer Medicine and Cancer Hospital 

Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U.

=============================  

Prof. Rachel Kerr, Oxford University  

 

Richel

 

Rachel Kerr is a medical oncologist and Associate Professor of Gastrointestinal Oncology in the Department of Oncology and at Oxford University Hospitals NIH. she holds a UK Department of Health Fellowship, and is Clinical Director of the Phase 3 Trials at the Oncology Clinical Trials Office (OCTO).

=========================  

1

Dr. Elizabeth Charlotte Moser, MD PhD MBA

 

 Chief Medical Officer of Deka Biosciences Inc, Germantown,   

 

 Former Vice President, Elekta, Former Vice President Clinical Development at Galera Therapeutics, Inc., USA, Former Chief Scientific Officer, Nanocan Therapeutics, Princeton, USA.

 

The present lecture is a part of her Dr. Moser’s Presentation  “ Personalized complication predictor tool in oncology practice”  5th  Global Health Catalyst Summit at Harvard Medical School , Boston, Ma, USA

 

2

Prof. Ahmed Elzawawy, MD, PhD

Founding Chair, win-win Scientific initiative & Co-founder & Chair, Board of Directors, GO-U & Global Oncology-Implementing Science Courses and program & Founding President, ICEDOC & Past President, AORTIC & Prof. Clinical Oncology, Suez Canal University &Chair. Clinical and Radiation Oncology Center , Port Said, Egypt.    

 

==========================   

Further reading:

 “ Approaching Global Oncology. The win-win model”

https://iopscience.iop.org/book/978-0-7503-3075-6   The first book summary (in the front Matter) and the first chapter are free online. 

======================

-How to join the course , registration and login    https://icedoc.website/cms/mod/zoom/view.php?id=12

- Direct link to this session :  Zoom

https://us06web.zoom.us/j/89166936468?pwd=b4wyaXsjaTnOJCLH9q5jk1EtJRhcaD.1